Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057150
Filing Date
2024-05-09
Accepted
2024-05-09 16:38:18
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-20240331.htm   iXBRL 10-Q 1565906
2 EX-10.1 crnx-ex10_1.htm EX-10.1 462360
3 EX-31.1 crnx-ex31_1.htm EX-31.1 25887
4 EX-31.2 crnx-ex31_2.htm EX-31.2 25844
5 EX-32.1 crnx-ex32_1.htm EX-32.1 9347
  Complete submission text file 0000950170-24-057150.txt   8333662

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20240331.xsd EX-101.SCH 1187536
67 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20240331_htm.xml XML 1492962
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 24931406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)